Temozolomide showed rapid activity in a patient with refractory CNS monomorphic epitheliotropic T cell lymphoma

Lymphoma
26/09/2020

Ann Hematol. 2020 Sep 25. doi: 10.1007/s00277-020-04282-1. Online ahead of print.

NO ABSTRACT